| P50 | author | Henrik Zetterberg | Q6252048 |
| | Kenneth S. Kosik | Q6390661 |
| | Eric M. Reiman | Q56863017 |
| | Lishuang Shen | Q61161065 |
| | Leo A Kim | Q64707170 |
| | Enmanuelle Pardilla-Delgado | Q85519558 |
| | Francisco Lopera | Q86508238 |
| | Jianling Ji | Q87737558 |
| | Joseph F Arboleda-Velasquez | Q88497533 |
| | David Leyton-Cifuentes | Q91106750 |
| | Pierre N Tariot | Q91106754 |
| | Yakeel T Quiroz | Q91106757 |
| | Yinghua Chen | Q91132428 |
| | Silvia Rios-Romenets | Q117234689 |
| | Edmarie Guzmán-Vélez | Q117234690 |
| | Juliana Acosta-Uribe | Q125308606 |
| | Rebecca A Reiman | Q125308761 |
| | Kaj Blennow | Q28321550 |
| | Matthew A Lalli | Q56335403 |
| | Reisa Sperling | Q56862977 |
| P2093 | author name string | Matthew J Huentelman | |
| | Yi Su | |
| | Kewei Chen | |
| | Michael O'Hare | |
| | Keith A Johnson | |
| | John B Miller | |
| | Pradeep Thiyyagura | |
| | Ji Luo | |
| | Xiaowu Gai | |
| | Aaron P Schultz | |
| | Margarita Giraldo | |
| | Claudia Marino | |
| | Moiz Bootwalla | |
| | Daniel J Norton | |
| | Santiago Delgado-Tirado | |
| | Arabiye Artola | |
| | Dhanesh Amarnani | |
| | Ana Baena | |
| | Kahira L Saez-Torres | |
| | Marcus Naymik | |
| | Justin S Sanchez | |
| | Natalia Chmielewska | |
| | David Aguillon | |
| | Gyungah R Jun | |
| P2860 | cites work | Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain | Q24308258 |
| | Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo | Q28131779 |
| | Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease | Q60961744 |
| | Integrating single-cell transcriptomic data across different conditions, technologies, and species | Q88243551 |
| | Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease | Q28238269 |
| | A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries | Q30475515 |
| | Disruption of functional connectivity in clinically normal older adults harboring amyloid burden | Q30492809 |
| | Graphical analysis of PET data applied to reversible and irreversible tracers | Q30620159 |
| | APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease | Q33629402 |
| | Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. | Q33769359 |
| | Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. | Q34940642 |
| | Amyloid-β associated cortical thinning in clinically normal elderly | Q35053524 |
| | Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study | Q35164302 |
| | Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia | Q35577335 |
| | Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly | Q35850701 |
| | Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide | Q36384642 |
| | A rapid and cost-effective method for genotyping apolipoprotein E gene polymorphism | Q36454644 |
| | Tau positron emission tomographic imaging in aging and early Alzheimer disease | Q36535275 |
| | Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study | Q36538745 |
| | Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. | Q36568066 |
| | Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease. | Q36594535 |
| | A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease | Q37231376 |
| | Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study. | Q39781531 |
| | A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807 | Q42253028 |
| | Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy | Q42330310 |
| | Pure progressive amnesia and the APPV717G mutation | Q43233191 |
| | Validity and reliability of the CERAD-Col neuropsychological battery | Q44545573 |
| | Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces | Q45176597 |
| | Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. | Q45810537 |
| | Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions | Q46398183 |
| | Diagnostic criteria for neuropathologic assessment of Alzheimer's disease | Q48662480 |
| | Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease | Q50051841 |
| | Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study. | Q51020924 |
| | A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression. | Q53408831 |
| | Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs). | Q55023550 |
| | Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. | Q55178076 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1680-1683 | |
| P577 | publication date | 2019-11-04 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report | |
| P478 | volume | 25 | |